Clinical trials
Phase 2 Epilepsy trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Terminated | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Equilibre Biopharmaceuticals B.V. | 2 |
| Takeda | 2 |
| Bial - Portela C S.A. | 1 |
| MGC Pharmaceuticals d.o.o | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 6 |
| Seizures | 3 |
| Epilepsies, Myoclonic | 2 |
| Lennox Gastaut Syndrome | 2 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Drug Resistant Epilepsy | 1 |
| Hypoxia-Ischemia, Brain | 1 |
| Malformations of Cortical Development | 1 |
| Nervous System Diseases | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.